ArticleFrontiers in oncology2025
Development and evaluation of a clinical-biochemical nomogram for differentiating pleomorphic adenoma and Warthin's tumor in the parotid gland.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aims to construct and evaluate an integrated nomogram model that combines clinical characteristics and biochemical blood markers to enable accurate and cost-effective differentiation between PA and WT. Methods: A retrospective analysis was carried out on patients diagnosed with PA and WT at the First Affiliated Hospital of Guangxi Medical University between 2013 and 2022. The participants were randomly allocated to the training set or validation set in a 3:1 ratio. Independent predictors were identified using the Least Absolute Shrinkage and Selection Operator (LASSO) and logistic regression. Based on these predictor variables, a nomogram model was developed. The study systematically evaluated the diagnostic performance, calibration effects, and clinical utility of the model through the application of receiver operating characteristic curves (ROC), calibration curves, decision curve analysis (DCA), and clinical impact curves (CIC). Results: The study cohort included 249 patients with PA and 173 with WT. The participants were split into a training set of 316 and a validation set of 106. Six independent predictors were identified: sex, age, smoking history, bilateral parotid involvement, white blood cell (WBC) count, and postprandial blood glucose at 2 hours (PBG2h). The AUC of the nomogram on the training set was 0.951, and the sensitivity, specificity and accuracy were 0.91, 0.906 and 0.908, respectively; on the validation set, these metrics were 0.934, 0.918, 0.844 and 0.887, respectively. The calibration curves were in close alignment with the ideal diagonals, indicating that the model has excellent calibration performance. Significant net clinical benefit was observed in the DCA and CIC analyses when the threshold probabilities were in the range of 0.05 to 0.97 for the training set and 0.07 to 0.96 for the validation set. Conclusion: This study presents the first nomogram model integrating clinical features and biochemical indicators for preoperative differentiation between PA and WT. The model offers an accurate, cost-effective tool to support personalized treatment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.